Quantifying the utility of taking pills for preventing adverse health outcomes: a cross-sectional survey.
| dc.contributor.author | Hutchins, Robert | |
| dc.contributor.author | Pignone, Michael P | |
| dc.contributor.author | Sheridan, Stacey L | |
| dc.contributor.author | Viera, Anthony J | |
| dc.coverage.spatial | England | |
| dc.date.accessioned | 2018-01-01T14:44:42Z | |
| dc.date.available | 2018-01-01T14:44:42Z | |
| dc.date.issued | 2015-05-11 | |
| dc.description.abstract | OBJECTIVES: The utility value attributed to taking pills for prevention can have a major effect on the cost-effectiveness of interventions, but few published studies have systematically quantified this value. We sought to quantify the utility value of taking pills used for prevention of cardiovascular disease (CVD). DESIGN: Cross-sectional survey. SETTING: Central North Carolina. PARTICIPANTS: 708 healthcare employees aged 18 years and older. PRIMARY AND SECONDARY OUTCOMES: Utility values for taking 1 pill/day, assessed using time trade-off, modified standard gamble and willingness-to-pay methods. RESULTS: Mean age of respondents was 43 years (19-74). The majority of the respondents were female (83%) and Caucasian (80%). Most (80%) took at least 2 pills/day. Mean utility values for taking 1 pill/day using the time trade-off method were: 0.9972 (95% CI 0.9962 to 0.9980). Values derived from the standard gamble and willingness-to-pay methods were 0.9967 (0.9954 to 0.9979) and 0.9989 (95% CI 0.9986 to 0.9991), respectively. Utility values varied little across characteristics such as age, sex, race, education level or number of pills taken per day. CONCLUSIONS: The utility value of taking pills daily in order to prevent an adverse CVD health outcome is approximately 0.997. | |
| dc.identifier | ||
| dc.identifier | bmjopen-2014-006505 | |
| dc.identifier.eissn | 2044-6055 | |
| dc.identifier.uri | ||
| dc.language | eng | |
| dc.publisher | BMJ | |
| dc.relation.ispartof | BMJ Open | |
| dc.relation.isversionof | 10.1136/bmjopen-2014-006505 | |
| dc.subject | cost-effectiveness | |
| dc.subject | medical decision making | |
| dc.subject | utility analysis | |
| dc.subject | Adult | |
| dc.subject | Aged | |
| dc.subject | Attitude to Health | |
| dc.subject | Cardiovascular Agents | |
| dc.subject | Cardiovascular Diseases | |
| dc.subject | Cross-Sectional Studies | |
| dc.subject | Drug Administration Schedule | |
| dc.subject | Female | |
| dc.subject | Humans | |
| dc.subject | Male | |
| dc.subject | Middle Aged | |
| dc.subject | North Carolina | |
| dc.subject | Patient Compliance | |
| dc.subject | Pharmaceutical Preparations | |
| dc.subject | Preventive Medicine | |
| dc.subject | Quality of Life | |
| dc.subject | Young Adult | |
| dc.title | Quantifying the utility of taking pills for preventing adverse health outcomes: a cross-sectional survey. | |
| dc.type | Journal article | |
| duke.contributor.orcid | Viera, Anthony J|0000-0001-5770-2052 | |
| pubs.author-url | ||
| pubs.begin-page | e006505 | |
| pubs.issue | 5 | |
| pubs.organisational-group | Clinical Science Departments | |
| pubs.organisational-group | Community and Family Medicine | |
| pubs.organisational-group | Duke | |
| pubs.organisational-group | Medicine | |
| pubs.organisational-group | Medicine, General Internal Medicine | |
| pubs.organisational-group | School of Medicine | |
| pubs.organisational-group | Temp group - logins allowed | |
| pubs.publication-status | Published online | |
| pubs.volume | 5 |
Files
Original bundle
- Name:
- Quantifying the utility of taking pills for preventing adverse health outcomes: a cross-sectional survey.pdf
- Size:
- 820.93 KB
- Format:
- Adobe Portable Document Format